Related Experiment Video

Updated: Dec 30, 2025

Mouse Electroacupuncture Fixation Device Fabrication for Electroacupuncture Pretreatment in Diabetic Cardiomyopathy Mouse Model
05:58

Mouse Electroacupuncture Fixation Device Fabrication for Electroacupuncture Pretreatment in Diabetic Cardiomyopathy Mouse Model

Published on: April 18, 2025

502

Role of microRNA in diabetic cardiomyopathy: From mechanism to intervention

Rui Guo1, Sreejayan Nair1

  • 1University of Wyoming, School of Pharmacy, College of Health Science and Center for Cardiovascular Research and Alternative Medicine, Laramie, WY 82071, USA.

Biochimica Et Biophysica Acta. Molecular Basis of Disease
|March 28, 2017
PubMed

Insights

Diabetic cardiomyopathy, a heart complication in diabetes, involves complex mechanisms. MicroRNAs show promise as novel diagnostic and therapeutic targets for this condition.

Area of Science:

  • Cardiology
  • Molecular Biology
  • Genetics

Background:

  • Diabetic cardiomyopathy is a serious heart complication in diabetic patients, leading to heart failure.
  • Its underlying mechanisms remain unclear, despite characterized by diastolic dysfunction, hypertrophy, and systolic dysfunction.
  • MicroRNAs, small non-coding RNAs, are increasingly implicated in diabetes and its complications.

Purpose of the Study:

  • To review recent studies on the role of microRNA in diabetic cardiomyopathy.
  • To explore microRNA as a potential diagnostic and therapeutic target.

Main Methods:

  • Literature review of recent studies.
  • Analysis of microRNA's involvement in diabetic cardiomyopathy pathogenesis.

Main Results:

  • MicroRNAs play a significant role in the development of diabetic cardiomyopathy.
  • Emerging evidence suggests microRNAs are key players in diabetes-related heart dysfunction.

Conclusions:

  • MicroRNAs represent a promising avenue for understanding and treating diabetic cardiomyopathy.
  • Further research into microRNA's function could lead to novel therapeutic strategies for diabetic heart disease.

Keywords:
BiomarkerDiabetic cardiomyopathyHeart failureMechanismTherapeutic interventionmicroRNA

More Related Videos

Modeling and Evaluation of Murine Diabetic Cardiomyopathy Model06:22

Modeling and Evaluation of Murine Diabetic Cardiomyopathy Model

Published on: November 29, 2024

1.3K
In Vivo Nanovector Delivery of a Heart-specific MicroRNA-sponge09:53

In Vivo Nanovector Delivery of a Heart-specific MicroRNA-sponge

Published on: June 15, 2018

7.9K

Related Concept Videos

Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
253
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
385
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
380
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
800
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.6K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
23.8K